Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Ann Thorac Surg ; 108(1): 196-202, 2019 07.
Artigo em Inglês | MEDLINE | ID: mdl-30853591

RESUMO

BACKGROUND: Postoperative pneumonia (POP) is a severe complication of major lung resection. The objective of this study was to describe the current epidemiology and appropriateness of antibiotic prescriptions in severe POP, 4 years after implementation of an antimicrobial stewardship program that was based on weekly multidisciplinary review of all antibiotic therapies. METHODS: This study was a retrospective analysis of a prospectively collected database. It included all cases of severe POP occurring within 30 days after major lung resection of in a 1,500-bed hospital between 2013 and 2015. Criteria for severe POP were acute respiratory failure, severe sepsis, or a rapidly extensive pulmonary infiltrate. The study collected data on incidence, clinical outcomes, and microbiological analyses. Appropriateness of antibiotic prescribing was assessed by quality indicators previously validated in the literature. RESULTS: Over the study period, 1,555 patients underwent major lung surgery. Severe POP occurred in 91 patients (5.8%; confidence interval, 4.7%; 7.0%), with a mortality rate of 9.0% (8 of 91; confidence interval, 3.0%; 14.6%). In POP with positive microbiological results, the proportion of gram-negative bacteria other than Haemophilus was 76% (50 of 66 cases). All patients (91 of 91) had respiratory samples taken within 24 hours after the start of antibiotics; empiric therapy was concordant with the guideline in 80% (69 of 86), and it was switched to pathogen-directed therapy in 74% (46 of 62). In 71 of 91 patients (78%), the antibiotic duration was up to 7 days. CONCLUSIONS: This study reported a high proportion of gram-negative bacteria in severe POP. Four years after implementation of the program, quality indicators of antibiotic prescribing were all >70%. The rate of de-escalation to pathogen-directed therapy could be improved, however.


Assuntos
Antibacterianos/uso terapêutico , Pneumonectomia/efeitos adversos , Pneumonia Bacteriana/tratamento farmacológico , Complicações Pós-Operatórias/tratamento farmacológico , Adulto , Idoso , Idoso de 80 Anos ou mais , Gestão de Antimicrobianos , Bactérias/isolamento & purificação , Farmacorresistência Bacteriana , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Pneumonia Bacteriana/epidemiologia , Pneumonia Bacteriana/etiologia , Complicações Pós-Operatórias/epidemiologia , Estudos Retrospectivos
2.
Int J Infect Dis ; 64: 93-95, 2017 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-28951103

RESUMO

An unusual case of pleural empyema related to Nocardia farcinica and Ureaplasma urealyticum, occurring after autologous haematopoietic stem cell transplantation in a 30-year-old patient with lymphoma, is reported. This case illustrates the role of repeated and comprehensive microbiological investigations and the contribution of molecular techniques in reaching the aetiological diagnosis.


Assuntos
Linfoma de Células B/complicações , Nocardiose/diagnóstico , Pleuropneumonia/diagnóstico , Reação em Cadeia da Polimerase , Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada , Infecções por Ureaplasma/diagnóstico , Ureaplasma urealyticum , Adulto , DNA Bacteriano/análise , Humanos , Masculino , Tipagem Molecular , Nocardia , Nocardiose/complicações , Nocardiose/diagnóstico por imagem , Nocardiose/microbiologia , Pleuropneumonia/complicações , Pleuropneumonia/microbiologia , RNA Ribossômico 16S/análise , Infecções por Ureaplasma/complicações , Ureaplasma urealyticum/genética
3.
Infect Dis Ther ; 4(3): 307-19, 2015 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-26334238

RESUMO

INTRODUCTION: Surgical resection of a malignant bone tumor (BT) or soft tissue tumor (STT), with or without prosthetic replacement, carries a high risk of developing postoperative infections. There is limited knowledge on the bacteriological spectrum of these postsurgical infections that necessitate empirical antibiotic therapy. The aim of this study was to analyze the incidence and microbiological features of site infections following BT or STT resection. METHODS: In this retrospective mono-center study, we analyzed the surgical and bacteriological data of all consecutive patients who developed an infection after surgical resection of a BT or STT between January 2010 and April 2014. RESULTS: Seventy-two consecutive patients who developed an infection on the site of surgical treatment for a BT (n = 42) or SST (n = 30) were included. Polymicrobism was frequently observed, more often associated with STTs (93%) than BTs (71%; P = 0.03). Gram-negative bacteria were more frequently isolated in STTs (55%) than in BTs (26%; P = 0.01) and non-prosthesis-associated infections (54%) than prosthesis-associated infections (29%; P = 0.04), whereas staphylococci were more frequently found in BTs (76%) than in STTs (52%; P = 0.03). Overall, we found gram negatives in 82% of early acute infections, 11% of chronic infections and 7% of late acute infections (P < 0.01). CONCLUSION: Postoperative infections in patients after surgical resection of BTs or STTs were often polymicrobial, especially following STTs. Causative bacteria were often gram negatives in STTs and non-prosthesis-associated infections, whereas staphylococci were predominant in BTs. Based on these findings, we recommend antibiotic coverage of both gram-positive and -negative bacteria with a combination of broad-spectrum antibiotics in STTs and antistaphylococcal antibiotics as first-line therapy in infections following BT surgery.

4.
J Clin Microbiol ; 43(7): 3564-6, 2005 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-16000508

RESUMO

A yellow-pigmented rod- to coccoid-shaped coryneform microorganism was isolated from the blood of a patient with acute myeloid leukemia. It was identified by 16S rRNA gene sequencing as a previously undescribed species of Janibacter. The isolate was susceptible to penicillins, aminoglycosides, fluoroquinolones, and glycopeptides.


Assuntos
Infecções por Actinomycetales/microbiologia , Actinomycetales/classificação , Actinomycetales/isolamento & purificação , Bacteriemia/microbiologia , Actinomycetales/genética , Doença Aguda , Genes de RNAr , Humanos , Leucemia Mieloide/complicações , Masculino , Pessoa de Meia-Idade , Dados de Sequência Molecular , Fenótipo , Filogenia , RNA Ribossômico 16S/genética , Análise de Sequência de DNA
5.
J Clin Microbiol ; 41(3): 1337-8, 2003 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-12624081

RESUMO

Acinetobacter ursingii has not been reported in infectious processes apart from its recent description as a new species. A bacteremia caused by A. ursingii in a patient with a pulmonary adenocarcinoma confirms that this microorganism is an opportunistic human pathogen. The isolate was susceptible to imipenem, aminoglycosides, rifampin, and fluoroquinolones.


Assuntos
Infecções por Acinetobacter/microbiologia , Acinetobacter/isolamento & purificação , Bacteriemia/microbiologia , Infecções Oportunistas/microbiologia , Acinetobacter/efeitos dos fármacos , Antibacterianos/farmacologia , Humanos , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA